跳至主要内容
临床试验/ACTRN12619001594112
ACTRN12619001594112已完成未知

ImplEMenting a nurse-coordinated, INtegrated, shared-care model involving specialists and general practitioners in breast cancer post-treatmENT follow-up: a Phase II randomised controlled trial (The EMINENT Trial)

Professor Raymond Chan0 个研究点目标入组 63 人开始时间: 2019年11月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
63

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Educational / counselling / training
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients who
  • - are treated at the Princess Alexandra Hospital
  • - following criteria will be considered for inclusion in the study:
  • - are from 4 weeks pre-completion up to 18 months after completion of adjuvant treatment for early stage breast cancer patients (including Ductal Carcinoma In-Situ (DCIS) and locally advanced) at the Princess Alexandra Hospital; OR within 4 weeks to 18 months post-surgery if they are not scheduled for any further adjuvant therapy
  • - have received a diagnosis of curable early breast cancer (i.e. no distant metastases);
  • - are able to speak and read English;
  • - are at least 18 years of age;
  • - are ambulatory patient at the time of recruitment;
  • - have an Eastern Cooperative Oncology Group performance status 0 or 1;
  • - are able to nominate a GP to be involved in their follow-up; and
  • - have access to a telephone.

排除标准

  • - the presence of severe mental, cognitive or physical conditions that would limit the patient’s ability to participate.
  • - breast cancer recurrence
  • - presence of distant metastases

研究者

发起方
Professor Raymond Chan

相似试验